In conjunction with Institut Kanser Negara's (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.
AstraZeneca Malaysia has launched its Evusheld monoclonal antibody combination in local private hospitals for the prevention of Covid-19 in high-risk individuals. In a recent statement, the company said the National Pharmaceutical Regulatory Agency (NPRA) had granted conditional registration for Evusheld in May this year for the pre-exposure prophylaxis (prevention) of Covid-19 in adults and adolescents aged 12 years and older weighing at least 40kg who are unlikely to mount an adequate immune response to Covid-19 vaccination, or for whom Covid-19 vaccination is not recommended.
LUNG Cancer Network Malaysia (LCNM), AstraZeneca and Qualitas Medical Group are partnering with Beacon Hospital, Subang Jaya Medical Centre and Sunway Medical Centre to provide free lung cancer screening to Malaysians.
Health Care Partners Collaborate On Lung Cancer Diagnosis With AI Tech galencentre.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from galencentre.org Daily Mail and Mail on Sunday newspapers.